No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
AU Stock MarketDetailed Quotes
CYP Cynata Therapeutics Ltd
- 0.180
- 0.0000.00%
20min DelayTrading Dec 16 14:38 AET
32.54MMarket Cap-3.33P/E (Static)
0.185High0.170Low551.53KVolume0.185Open0.180Pre Close99.31KTurnover0.34552wk High0.42%Turnover Ratio180.80MShares0.12052wk Low-0.054EPS TTM23.59MFloat Cap0.640Historical HighLossP/E (Static)131.05MShs Float0.105Historical Low-0.054EPS LYR8.33%Amplitude--Dividend TTM4.50P/B1Lot Size--Div YieldTTM
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Cynata Therapeutics Started at Spec Buy by Euroz Hartleys >CYP.AU
Cynata Therapeutics Started With A$0.75/Share Target Price by Euroz Hartleys>CYP.AU
Cynata Therapeutics Ltd: Annual Report to Shareholders
Cynata Therapeutics Ltd: Appendix 4E & Annual Report
Cynata Therapeutics Advances Key Clinical Trials in June Quarter
Here's Why We're Watching Cynata Therapeutics' (ASX:CYP) Cash Burn Situation
Trending AU Stocks
ASX High Dividend ASX High Dividend